Enable JavaScript to visit this website.

What is XELJANZ/XELJANZ XR?

XELJANZ/XELJANZ XR (tofacitinib) is a prescription medicine called a Janus kinase (JAK) inhibitor used to treat:

  • Adults with active psoriatic arthritis in which methotrexate or other similar medicines called nonbiologic disease-modifying antirheumatic drugs (DMARDs) did not work well.

It is not known if XELJANZ/XELJANZ XR is safe and effective in children or in people with Hepatitis B or C.

XELJANZ/XELJANZ XR is not recommended for people with severe liver problems.

If you no longer wish to receive information or updates about XELJANZ/XELJANZ XR for your active psoriatic arthritis, please enter your email address below and we will remove you from our contact list

*REQUIRED FIELD

For more information or assistance, please Contact Us.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.